📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Max Healthcare to Discuss Q3 & 9M FY26 Results in Earnings Call on Feb 6, 2026
Max Healthcare Institute Limited has scheduled its Q3 and 9M FY26 earnings conference call for February 6, 2026, at 11:30 AM IST. The financial results for the period ending December 31, 2025, will be officially declared on February 5, 2026. The company currently operates a network of 20 healthcare facilities with approximately 5,200 beds across India. Senior management will provide commentary on financial performance and strategic initiatives during the interactive session.
Key Highlights
Earnings call set for Feb 6, 2026, following result declaration on Feb 5, 2026
Company manages a significant footprint of 20 healthcare facilities and ~5,200 beds
Discussion to include performance of core hospitals, Max@Home, and Max Labs diagnostic services
Dial-in details provided for international investors in HK, Singapore, UK, and USA
💼 Action for Investors
Investors should review the financial results on February 5 to evaluate margin trends and bed occupancy. Use the conference call to gain insights into the company's expansion plans and pathology business growth.
LT Foods Q3 Net Profit Rises 8% to ₹157 Cr; Declares ₹1 Interim Dividend
LT Foods reported a strong 23.5% YoY growth in consolidated revenue, reaching ₹2,809.20 crore for the quarter ended December 31, 2025. Consolidated net profit for the quarter increased by 8.2% YoY to ₹157.35 crore, while 9-month profits reached ₹489.71 crore. The company declared a second interim dividend of ₹1 per share (100% of face value) with a record date of February 2, 2026. Additionally, the company transitioned its internal audit function to an in-house head supported by EY, following the resignation of Protiviti India.
Key Highlights
Consolidated revenue from operations grew 23.5% YoY to ₹2,80,920 lakh in Q3 FY26.
Net profit for the quarter stood at ₹15,735 lakh, up from ₹14,538 lakh in the previous year's corresponding quarter.
Declared a 2nd interim dividend of ₹1 per equity share with a record date of February 2, 2026.
9M FY26 consolidated revenue reached ₹8,03,885 lakh, a significant jump from ₹6,45,310 lakh in 9M FY25.
Appointed Ms. Neha Sharma as Internal Auditor, supported by EY for select audits, effective January 28, 2026.
💼 Action for Investors
Investors should take note of the robust top-line growth and consistent dividend payouts as indicators of strong market demand. The transition in internal audit to a hybrid model involving EY suggests a continued commitment to governance and internal controls.
Oberoi Realty Appoints Aditi Mittal as EVP and Business Head for North Zone
Oberoi Realty has appointed Ms. Aditi Mittal as Executive Vice President - Business Head (North Zone) effective January 28, 2026. Ms. Mittal is a seasoned professional with over 19 years of experience in Real Estate, Cement, and Consulting, specializing in Strategic Planning and Sales. This marks a return to the company for Ms. Mittal, who previously served at Oberoi Realty for over five years between 2013 and 2018. Her appointment is expected to strengthen the company's leadership and operational focus in the North Zone.
Key Highlights
Ms. Aditi Mittal appointed as Executive Vice President - Business Head (North Zone) effective January 28, 2026
Brings over 19 years of experience in Investor Relations, Strategic Planning, and Project Management
Educational qualifications include being a Chartered Accountant and an MBA from the Indian School of Business (ISB)
Previously associated with Oberoi Realty from May 2013 to October 2018 and most recently worked with Dalmia Bharat Limited
💼 Action for Investors
Investors should view this as a positive step in strengthening regional leadership with a candidate who has prior institutional knowledge of the company. Monitor for any new project announcements or strategic shifts in the North Zone following this appointment.
Gujarat Gas Q3 FY26: PAT Rises 20% to ₹266 Cr; EBITDA/SCM Hits ₹6.5 Despite Volume Pressure
Gujarat Gas reported a 20% YoY increase in PAT to ₹266 crore for Q3 FY26, driven by improved EBITDA margins of ₹6.5 per SCM. While industrial volumes declined 10% QoQ to 3.93 MMSCMD due to propane competition in Morbi, the CNG segment grew 11% YoY. The company expects its merger scheme to conclude by April 2026 and has engaged McKinsey for strategic expansion. Management maintains an EBITDA margin guidance of ₹5.5 to ₹6.5 per SCM for the full year.
Key Highlights
PAT grew 20% YoY to ₹266 crore; EBITDA margin per SCM improved to ₹6.5 from ₹5.04.
Industrial volumes dropped 10% QoQ to 3.93 MMSCMD, impacted by lower propane prices in Morbi.
CNG volumes rose 11% YoY, supported by a 14% growth in the CNG vehicle base to 16.94 lakh.
APM gas shortfall increased to 51%, with CNG shortfall at 64% being met by spot and long-term gas.
Merger completion expected by end of April 2026; FY26 Capex planned at ₹650-700 crore.
💼 Action for Investors
Investors should monitor the impact of the ₹4.50/SCM price reduction on Morbi volume recovery and the finalization of the merger. The company's ability to maintain margins despite APM cuts is a key positive, but industrial volume volatility remains a risk.
Larsen & Toubro Concludes Board Meeting on January 28, 2026
Larsen & Toubro Limited (L&T) has officially concluded its Board Meeting held on January 28, 2026. The meeting was a full-day session, commencing at 9:30 a.m. and concluding at 6:15 p.m. While this specific filing is a procedural notification of the meeting's conclusion, it typically precedes the release of quarterly financial results or major corporate announcements. Investors should look for the detailed outcome document for specific financial performance data.
Key Highlights
Board meeting held on January 28, 2026, has officially concluded.
The session lasted approximately 8 hours and 45 minutes, starting at 9:30 a.m.
The meeting concluded at 6:15 p.m. as per the regulatory filing.
This filing serves as a procedural update to the stock exchanges.
💼 Action for Investors
This is a routine administrative update. Investors should monitor subsequent filings for the actual financial results or strategic decisions made during this session.
LT Foods Q3 Net Profit Up 8% to ₹157 Cr; Declares ₹1 Interim Dividend
LT Foods reported a 23.5% YoY increase in consolidated revenue to ₹2,809.20 crore for Q3 FY26. The company declared its second interim dividend of ₹1 per share, representing 100% of the face value. Net profit for the quarter rose to ₹157.35 crore from ₹145.39 crore in the previous year. The board also approved the appointment of Ms. Neha Sharma as the Internal Auditor, supported by EY for specific audits.
Key Highlights
Consolidated Revenue for Q3 FY26 rose 23.5% YoY to ₹2,809.20 crore.
Net Profit for the quarter increased 8.2% YoY to ₹157.35 crore.
Declared 2nd Interim Dividend of ₹1 per share with a record date of February 2, 2026.
9-month FY26 consolidated revenue stands at ₹8,038.85 crore compared to ₹6,453.10 crore YoY.
Basic EPS for the quarter improved to ₹4.53 from ₹4.13 in the year-ago period.
💼 Action for Investors
The strong revenue growth and dividend declaration reflect healthy operational performance. Investors may hold for long-term gains as the company scales its global footprint.
ASK Automotive Q3 FY26: PAT up 21% to ₹80 Cr, EBITDA Margins Expand to 13.4%
ASK Automotive reported its highest-ever quarterly revenue, EBITDA, and PAT in Q3 FY26, with consolidated revenue growing 18.5% YoY to ₹1,089 crore. The company's strategic shift away from the low-margin wheel assembly business (down 51.5%) led to significant margin expansion, with EBITDA margins rising 88 bps to 13.4%. Net profit for the quarter grew 21.3% YoY to ₹80 crore, driven by strong growth in Aluminium Light Weighting (+36%) and Advanced Braking Systems (+22%). Management highlighted that the new Karoli and Bangalore facilities are ramping up, contributing to better economies of scale.
Key Highlights
Consolidated Revenue grew 18.5% YoY to ₹1,089 Cr; excluding Wheel Assembly, growth was 28.0%
EBITDA increased 26.8% YoY to ₹146 Cr with margins expanding by 88 bps to 13.4%
PAT rose 21.3% YoY to ₹80 Cr, marking the highest-ever quarterly profit for the company
Aluminium Light Weighting Precision Solutions segment showed robust growth of 36% YoY
Strategic reduction in low-value Wheel Assembly business by 51.5% significantly improved overall profitability
💼 Action for Investors
Investors should favor the company's successful transition toward high-margin segments and its ability to outperform industry growth. The ramp-up of new manufacturing facilities provides a clear visibility for sustained earnings growth in the coming quarters.
ASK Automotive Q3 FY26 PAT Rises 21.3% to ₹80 Cr; EBITDA Margins Expand to 13.4%
ASK Automotive reported its highest-ever quarterly revenue, EBITDA, and PAT for Q3 FY26, with consolidated revenue growing 18.5% YoY to ₹1,089 crore. The company's EBITDA increased by 26.8% to ₹146 crore, driven by a strategic reduction in the low-margin wheel assembly business and improved capacity utilization at new facilities. Net profit (PAT) rose 21.3% YoY to ₹80 crore, while EBITDA margins expanded by 88 basis points to 13.4%. The Aluminum Lightweighting segment showed robust growth of 36% YoY, reflecting a successful shift towards a higher-value product mix.
Key Highlights
Consolidated Revenue grew 18.5% YoY to ₹1,089 Cr, significantly outperforming industry growth rates.
EBITDA margins improved to 13.4% from 12.5% YoY, aided by economies of scale and strategic product shifts.
Aluminum Lightweighting Precision Solutions (ALPS) revenue surged 36% YoY to ₹538 Cr in Q3 FY26.
Strategic reduction in low-margin Wheel Assembly business by 51.5% YoY to optimize the bottom line.
Maintains a dominant ~50% market share in the Indian 2W Advanced Braking systems segment.
💼 Action for Investors
Investors should take note of the significant margin expansion and the company's successful transition toward high-margin aluminum lightweighting components. The stock remains a strong play on the 2W recovery and EV premiumization trend given its 50% market share in braking systems.
ASK Automotive Q3 FY26 PAT Rises 12% YoY to ₹60.8 Cr; Re-appoints 4 Independent Directors
ASK Automotive reported a steady growth in its Q3 FY26 standalone performance, with revenue reaching ₹860 crore, a 5.7% increase year-on-year. Net profit for the quarter stood at ₹60.78 crore, up from ₹54.14 crore in the same period last year. The company also announced the re-appointment of four independent directors for a second three-year term, ensuring leadership continuity. For the nine-month period ended December 2025, the company achieved a total income of ₹2,447.52 crore and a profit of ₹168.51 crore.
Key Highlights
Standalone Revenue from operations grew to ₹860.00 crore in Q3 FY26 from ₹813.63 crore in Q3 FY25.
Profit After Tax (PAT) increased by 12.3% YoY to ₹60.78 crore for the quarter ended December 2025.
Earnings Per Share (EPS) improved to ₹3.08 for the quarter, up from ₹2.75 in the previous year's corresponding quarter.
Board approved the re-appointment of four Independent Directors for a second term of three years each starting in 2026.
Total income for the nine-month period ended December 31, 2025, reached ₹2,447.52 crore with a PAT of ₹168.51 crore.
💼 Action for Investors
The consistent YoY and QoQ growth in profitability indicates strong operational efficiency in the automotive components space. Investors may consider this a positive signal for long-term holding, supported by stable governance through the re-appointment of key board members.
ASK Automotive to Expand Braking System Capacity by 6 Crore Pcs with ₹35 Cr Investment
ASK Automotive has approved a significant capacity expansion for its Advanced Braking Systems (Brake Shoes and Disc Brake Pads) to meet rising demand in the two-wheeler segment. The company will add 6 crore pieces per annum to its existing 26 crore capacity, marking a 23% increase. The expansion involves setting up two new plants in Rajasthan with a capital outlay of approximately ₹35 crore, funded entirely through internal accruals. This move is triggered by high current capacity utilization of 90% and is expected to be commissioned by Q1 FY 2026-27.
Key Highlights
Proposed capacity addition of 6 crore pieces per annum for Brake Shoes and Disc Brake Pads
Total investment of approximately ₹35 crore to be financed through internal accruals
Existing capacity utilization stands at a high of 90%, necessitating the expansion
Two new plants to be established in Rajasthan with expected commissioning in Q1 FY 26-27
Expansion driven by increased demand supported by GST 2.0 reforms
💼 Action for Investors
Investors should view this as a positive growth indicator, as the expansion is funded internally and addresses high utilization levels. Monitor the company's ability to maintain margins while scaling up and the timely execution of the Rajasthan plants.
Sejal Glass Clarifies Board Meeting Agenda for Q3 FY26 Results
Sejal Glass Limited has issued a clarification regarding its upcoming Board Meeting scheduled for February 02, 2026. The company corrected a typographical error in its previous filing, clarifying that it will consider Unaudited Standalone Financial Results for the quarter and nine months ended December 31, 2025. The previous notice had incorrectly mentioned 'Audited' results, which is a standard procedural correction as quarterly results typically undergo a limited review rather than a full audit. All other details of the meeting remain unchanged.
Key Highlights
Board Meeting scheduled for February 02, 2026, remains on track.
Correction made from 'Audited' to 'Unaudited' standalone financial results.
Results pertain to the quarter and nine-month period ended December 31, 2025.
The filing was made in compliance with Regulation 29 of SEBI (LODR) Regulations, 2015.
💼 Action for Investors
No action is required as this is a routine administrative correction. Investors should focus on the actual financial performance to be disclosed on February 02, 2026.
India Power Corp (DPSCLTD) to Strike Off Step-Down Subsidiary IUPSPL by March 2026
India Power Corporation Limited has initiated the voluntary strike-off process for its step-down subsidiary, India Uniper Power Services Private Limited (IUPSPL). The subsidiary has a negligible financial footprint, contributing only 0.009% to the company's total income. With a net worth of approximately ₹120.18 Lakhs, its removal will not materially impact the consolidated financials. The process is expected to be finalized by March 31, 2026, as part of corporate streamlining.
Key Highlights
IUPSPL Board approved voluntary strike-off from the Registrar of Companies, West Bengal.
Subsidiary contributed only ₹6.74 Lakhs (0.009%) to the total income in the last financial year.
Net worth of the subsidiary stands at ₹120.18 Lakhs, representing 0.136% of the group's net worth.
The dissolution process is expected to be completed within 3 months, by March 31, 2026.
💼 Action for Investors
This is a routine administrative cleanup of a non-material subsidiary. Investors should remain focused on the company's core power distribution performance rather than this restructuring.
Emami Ltd Receives Cautionary Letter from NSE Over Secretarial Compliance Observations
Emami Limited received a cautionary letter from the National Stock Exchange (NSE) on January 27, 2026, regarding its Secretarial Compliance Report for the financial year ended March 31, 2025. The letter follows observations made by the Secretarial Auditor concerning adherence to SEBI Listing Regulations. The NSE has advised the company to be more careful in the future to prevent the recurrence of such lapses. Importantly, the company has stated that this regulatory advice has no impact on its financial or operational performance.
Key Highlights
Received cautionary letter from NSE on January 27, 2026, regarding FY25 compliance.
Observations were initially reported by the Secretarial Auditor in the Annual Secretarial Compliance Report.
NSE advised the company to strictly adhere to SEBI Listing Regulations moving forward.
Company confirms zero impact on financial, operational, or other activities.
💼 Action for Investors
This is a minor regulatory matter with no financial implications; no immediate action is required from investors.
Seamec Limited to Host Q3 FY26 Earnings Call on February 2, 2026
Seamec Limited has scheduled its Q3 FY 2025-26 earnings conference call for Monday, February 2, 2026, at 2:30 PM IST. The call will be hosted by Arihant Capital Markets Ltd and will feature senior management, including the Whole Time Director and CFO. This interaction provides an opportunity for investors to gain insights into the company's financial performance for the quarter ending December 2025. The company has clarified that no unpublished price sensitive information (UPSI) will be shared during the call.
Key Highlights
Earnings call scheduled for February 2, 2026, at 2:30 PM IST to discuss Q3 FY26 results.
Management representation includes Mr. Naveen Mohta (Whole Time Director) and Mr. Vinay Kumar Agarwal (CFO).
The call is being organized by Arihant Capital Markets Ltd.
Universal dial-in numbers provided are +91 22 6280 1466 and +91 22 7115 8826.
💼 Action for Investors
Investors should attend or review the transcript of the call to understand management's outlook on vessel utilization rates and the offshore services market. Key focus should be on any updates regarding new contracts or fleet expansion plans.
TVS Holdings Q3 PAT Drops to ₹21.2 Cr; Board Approves ₹500 Cr Debt Fundraise
TVS Holdings Limited reported a sharp decline in standalone performance for Q3 FY26, with revenue from operations falling to ₹57.95 Cr from ₹149.43 Cr in the previous year's corresponding quarter. Standalone Net Profit dropped significantly to ₹21.20 Cr compared to ₹85.07 Cr YoY, largely due to the absence of high dividend income and lower gains from investment sales. In a major strategic move, the Board approved raising up to ₹500 Cr through debt instruments like NCDs and Commercial Papers. The company also recognized a small exceptional loss of ₹0.32 Cr related to the implementation of New Labour Codes.
Key Highlights
Standalone Revenue from Operations decreased by 61% YoY to ₹57.95 Cr in Q3 FY26.
Net Profit for the quarter fell to ₹21.20 Cr from ₹85.07 Cr in Q3 FY25.
Board approved a fresh fundraise of up to ₹500 Cr via debt instruments including NCDs and bonds.
Exceptional item of ₹0.32 Cr recorded due to past period employee benefit liability under New Labour Codes.
Standalone Earnings Per Share (EPS) declined to ₹10.48 from ₹42.05 in the year-ago period.
💼 Action for Investors
Investors should be aware that as a holding company, TVS Holdings' standalone results are highly sensitive to dividend cycles and investment exits. Monitor the utilization of the proposed ₹500 Cr debt raise for potential expansion or refinancing activities.
L&T Allots 30,657 Equity Shares Under Employee Stock Option Schemes
Larsen & Toubro Limited (L&T) has allotted 30,657 equity shares to employees who exercised their options under the company's ESOP schemes. The allotment was approved by the Nomination & Remuneration Committee on January 28, 2026. These new shares will rank pari-passu with existing equity shares, meaning they carry the same dividend and voting rights. This is a routine administrative procedure with negligible impact on the overall share capital and earnings per share.
Key Highlights
Allotment of 30,657 equity shares to employees upon exercise of ESOP options.
Approved by the Nomination & Remuneration Committee (NRC) on January 28, 2026.
New shares rank pari-passu with existing equity shares in all respects.
The NRC meeting concluded within 30 minutes, from 9:00 a.m. to 9:30 a.m.
💼 Action for Investors
No action is required as this is a routine corporate event. The dilution caused by this allotment is minimal relative to L&T's total outstanding shares.
Ravindra Energy targets 476 MWp solar capacity and 5,000 unit e-tractor plant by FY27
Ravindra Energy is executing a dual-growth strategy focusing on distributed solar power and heavy-duty electric mobility. The company plans to scale its solar capacity from 187 MWp to 476 MWp by FY27, largely through rural feeder solarization under the KUSUM scheme. Its electric mobility subsidiary, EIM, is establishing a 5,000-unit annual capacity manufacturing plant in Pune, expected to commission by June 2026. The company utilizes a Battery-as-a-Service (BaaS) model to drive adoption in the 55-tonne e-tractor segment, targeting port and industrial logistics.
Key Highlights
Solar operational capacity projected to grow ~2.5x from 187 MWp to 476 MWp by FY27.
New e-tractor manufacturing facility in Talegaon, Pune with 5,000 units p.a. capacity to be commissioned by June 2026.
Current e-mobility order book stands at 263 units with 125 units already sold as of December 2025.
Strategic battery swapping network expansion targeting 100 stations by FY29 to support heavy-duty EV corridors.
Maintains a 6-year exclusivity agreement for assembling and distributing heavy CVs (>18 tonnes) with CATL battery support.
💼 Action for Investors
Investors should track the execution of the Talegaon plant commissioning in mid-2026 and the pace of solar capacity additions. The stock represents a niche play on heavy-duty EV adoption and rural energy infrastructure with a strong 5-year price CAGR of 32%.
L&T Announces Schedule for 9 Institutional Investor Meets and Global Roadshows (Feb-Mar 2026)
Larsen & Toubro (L&T) has disclosed a comprehensive schedule of nine investor interactions and conferences set to take place between February 2 and March 23, 2026. The schedule includes international Non-Deal Roadshows (NDRs) in Hong Kong and Singapore, as well as participation in major domestic conferences in Mumbai. These meetings involve high-profile global and domestic financial institutions such as Goldman Sachs, HSBC, Morgan Stanley, and Axis Capital. The company will use standard presentations already available on the stock exchange websites.
Key Highlights
9 scheduled interactions with institutional investor groups between February 2 and March 23, 2026
International Non-Deal Roadshows (NDRs) planned for Hong Kong (Feb 2-3) and Singapore (Feb 4-5)
Participation in 4 major flagship India conferences hosted by Nuvama, Axis Capital, IIFL, and Kotak
Engagement with top-tier global brokerages including Goldman Sachs, HSBC, Jefferies, and Morgan Stanley
💼 Action for Investors
These meetings are routine investor relations activities; investors should monitor for any new management commentary or updated investor presentations that may be released during this period.
Jai Corp Limited Dissolves Non-Material Subsidiary Jaicorp Welfare Limited
Jai Corp Limited has announced the official dissolution of its wholly-owned subsidiary, Jaicorp Welfare Limited, effective January 27, 2026. The subsidiary was previously identified as a non-material, un-listed entity that was not conducting any economic activity. This final strike-off follows the Board's approval for liquidation granted on November 22, 2025. The move is part of a routine corporate cleanup to eliminate inactive entities from the group structure.
Key Highlights
Jaicorp Welfare Limited officially struck off and dissolved by the MCA on January 27, 2026.
The entity was a wholly-owned, non-material subsidiary of Jai Corp Limited.
Liquidation process was initiated due to the subsidiary having no active economic operations.
Initial Board approval for the closure was communicated on November 22, 2025.
💼 Action for Investors
This is a routine administrative matter with no impact on the company's financial performance or operations. Investors should treat this as a neutral development.
Alembic Pharma Receives USFDA Final Approval for Difluprednate Ophthalmic Emulsion
Alembic Pharmaceuticals has secured final USFDA approval for Difluprednate Ophthalmic Emulsion, 0.05%, which is a generic version of Sandoz's Durezol. The product is used for treating inflammation and pain after ocular surgery and for endogenous anterior uveitis. This approval marks a continued expansion of the company's US product portfolio. With this addition, Alembic now holds a cumulative total of 233 USFDA approvals, including 213 final approvals.
Key Highlights
Received final USFDA approval for Difluprednate Ophthalmic Emulsion, 0.05%
Product is therapeutically equivalent to the reference listed drug Durezol by Sandoz Inc.
Indicated for ocular surgery inflammation and endogenous anterior uveitis
Company's cumulative USFDA approvals reach 233 (213 final and 20 tentative)
💼 Action for Investors
Investors should monitor the commercial launch and market share capture of this product in the US ophthalmic market. The steady stream of USFDA approvals remains a key driver for the company's international revenue growth.